Search
Search Results
##search.searchResults.foundPlural##
-
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2937PDF: 888HTML: 1755 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2105PDF: 1685HTML: 374 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1329PDF: 822HTML: 129 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1364HTML: 389PDF: 815 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
950PDF: 577HTML: 337 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1777PDF: 964HTML: 141 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3212PDF: 1427HTML: 5844Fig1-Ag-Pil: 222Ag-Pil Fig.2: 226 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
944PDF: 1204HTML: 106 -
SOLITARY PLASMACYTOMA
3843PDF: 2172HTML: 1219fIGURES 1,2: 212 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1514PDF: 936HTML: 222 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3289PDF: 2264HTML: 23320Untitled: 203Untitled: 215Untitled: 229 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2538PDF: 1127HTML: 138 -
-
-
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1648PDF: 1171HTML: 199 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2767PDF: 1802HTML: 3664Pellagatti Fig 1: 211Pellagatti Fig. 2: 207 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
991PDF: 534HTML: 7809 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1254PDF: 527HTML: 23038 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1183PDF: 1060HTML: 198 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3220PDF: 1004HTML: 2023 -
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
868PDF: 645HTML: 203 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3674PDF: 1435HTML: 181 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2112PDF: 1267Html: 277 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1822HTML: 1437PDF: 1078 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4796PDF: 1793HTML: 2131 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3757PDF: 1649HTML: 11573Figures Haase: 196 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3576PDF: 877HTML: 6710 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2180PDF: 925HTML: 408Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 212UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 340Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 238Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 176Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 188Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 256 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1049PDF: 1040HTML: 93







